Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Keep your eyes peeled for: Proposed rule changes: There was a proposal to reinterpret the Medicare exclusion for anti-obesity drugs so that obesity itself (not just when comorbid with another condition) might be considered a medically accepted indication. But that change was not finalized in April 2025
Acetyl-L-carnitine: An effective antioxidant against cryo-damage on research-subject spermatozoa with asthenospermia
After washing in PBS, primary antibodies (IgM-PE BioLegend 406507, IgD-APC BioLegend 405713, MARCO Santa Cruz sc-65353/ anti-rat PE Abcam ab97058 and Siglec-1 Biolegend 142417) diluted in PBS 10% FCS were incubated overnight at 4 C
Conclusions Targeting DNMT1 may mitigate lipid dysregulation and inflammation by reversing hypermethylation and restoring HNF4- and PPAR-dependent gene transcription, highlighting DNMT1 as a potential therapeutic target for MASLD
Citations Citations to this article as recorded by Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review Jinyi Li, Yuanda Liu Infectious Agents and Cancer .2026;[Epub] CrossRef 3,092 View 357 Download Crossref Review Hepatic neoplasm Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D
Expert Review of Neurotherapeutics
US$ 25.31
US$ 21.41
US$ 25.29
US$ 29.27
US$ 25.77
US$ 27.05
US$ 26.74
